Spikevax 2025-26 (6M-11Y) SYR 0.25ML
Ended Awarded
- Contract number
- SPE2DR26F9AW6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,354
Award facts
- Contract value 100% obligated
- $17,353.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,353.95 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine doses (6 months to 11 years, 0.25 mL syringes) on November 7, 2025, with completion required by December 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, demonstrates extensive capability in supplying vaccines and pharmaceutical products to Defense Health Agency and military healthcare systems. This delivery order for pediatric COVID-19 vaccine doses supports DLA's medical supply chain operations and reflects the company's established role as a primary pharmaceutical vendor within the Department of Defense healthcare procurement ecosystem. The competitively awarded order reflects AmerisourceBergen's proven ability to meet federal procurement requirements and its position as a key supplier within DLA's pharmaceutical distribution network for military and veteran healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F9AW6?
SPE2DR26F9AW6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DR26F9AW6 worth?
The government has obligated $17,354 on SPE2DR26F9AW6.
Is contract SPE2DR26F9AW6 an order under another contract?
Yes. SPE2DR26F9AW6 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9AW6 competed?
The extent of competition for SPE2DR26F9AW6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award